Case Report
Volume 8 Issue 3 - 2021
Tumors of the Gastrointestinal Stroma. Surgical Management and Tyrosinase Inhibitors (ITK)
Salvador Moreno Galeana1, Adrián Regalado Aquino2 and Juan Carlos Rivera Martínez3*
11Médico Residente de Cirugía General, Hospital de Especialidades Centro Médico Nacional La Raza, Ciudad de México, Mexico
2Médico Adscrito al Servicio de Cirugía General, Clínica de Cirugía de Organos Sólidos, Hospital de Especialidades Centro Médico Nacional La Raza, Ciudad de México, Mexico
3Médico Adscrito al Servicio de Cirugía General, Clínica de Intestino delgado, Hospital de Especialidades Centro Médico Nacional La Raza, Ciudad de México, Mexico
*Corresponding Author: Juan Carlos Rivera Martínez, Médico Adscrito al Servicio de Cirugía General, Clínica de Intestino delgado, Hospital de Especialidades Centro Médico Nacional La Raza, Ciudad de México, Mexico.
Received: February 17, 2021; Published: March 16, 2021


Gastrointestinal stromal tumors are tumors that can have a benign or malignant behavior. They originate from the interstitial cells of Cajal in the digestive tract. These entities have a slow growth and are recognized as a finding in imaging studies or in the intraoperative as a cause of intestinal occlusion, gastrointestinal bleeding or acute abdomen. Below we present two clinical cases with different presentations. The diagnosis is made with histopathology. Treatment of these tumors is essentially surgical, although it can be completed with targeted molecular therapy.

Keywords: GIST; Gastrointestinal Stromal Tumors; CD 117; Surgery; Tyrosine Kinase Inhibitors; Treatment


    1. Sanchez-Hidalgo JM., et al. “Gastrointestinal stromal tumors: A multidisciplinary challenge”. World Journal of Gastroenterology18 (2018): 1925-1941.
    2. Harlan LC., et al. “Gastrointestinal stromal tumors: treatment patterns of a population-based sample”. Journal of Surgical Oncology 111 (2015): 702-707.
    3. DeMatteo RP., et al. “Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival”. Annals of Surgery 231 (2000): 51-58.
    4. Rubin BP. “Gastrointestinal stromal tumours: an update”. Histopathology 48 (2006): 83-96.
    5. Pink D., et al. “Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases”. Journal of Clinical Oncology 23 (2005): 6809-6811.
    6. Maynard MA., et al. “Thyroid hormone inactivation in gastrointestinal stromal tumors”. The New England Journal of Medicine14 (2014): 1327-1334.
    7. Miettinen M., et al. “Tumores del estroma gastrointestinal en pacientes con neurofibromatosis 1: un estudio clínico-patológico y genético molecular de 45 casos”. International Journal of Surgical Pathology 30 (2006): 90-96.
    8. Díaz Delgado M., et al. “Tumores del estroma gastrointestinal múltiples no metastásicos: Aspectos diferenciales”. Revista Española de Enfermedades Digestivas8 (2010): 489-497.
    9. Janeway KA and Weldon CB. “Pediatric gastrointestinal stromal tumor”. Seminars in Pediatric Surgery 21 (2012): 31-43.
    10. Kamiyama Y., et al. “18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors”. World Journal of Surgery 29 (2005): 1429-1435.
    11. Hassanzadeh-Rad A., et al. “The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis”. European Journal of Gastroenterology and Hepatology 31 (2016): 929-935.
    12. Fletcher CD., et al. “Diagnosis of gastrointestinal stromal tumors: A consensus approach”. Human Pathology 33 (2002): 459-465.
    13. Eriksson M., et al. “Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?” European Journal of Cancer 59 (2016): 128-133.
    14. Everett M and Gutman H. “Surgical management of gastrointestinal stromal tumors: analysis of outcome with respect to surgical margins and technique”. Journal of Surgical Oncology 98 (2008): 588-593.
    15. Koga T., et al. “Necessity for resection of gastric gastrointestinal stromal tumors ≤ 20 mm”. Anticancer Research 35 (2015): 2341-2344.
    16. Andtbacka RH., et al. “Surgical resection of gastrointestinal stromal tumors after treatment with imatinib”. Annals of Surgical Oncology 14 (2007): 14-24.
    17. Bamboat ZM and DeMatteo RP. “Metastasectomy for gastrointestinal stromal tumors”. Journal of Surgical Oncology1 (2014): 23-27.
    18. Sugarbaker PH. “Sarcomatosis and Imatinib-Resistant GISTosis: Diagnosis and Therapeutic Options. Cytoreductive Surgery Perioperative Chemotherapy for Peritoneal Surface Malignancy Textbook and Video Atlas”. 1st ed. Woodbury, CT: Cine-Med Publishing, Inc (2012): 127-136.
    19. Ye YJ., et al. “Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)”. European Journal of Surgical Oncology 35 (2009): 787-792.
    20. Serralta AS., et al. “Combined liver transplantation plus imatinib for unresectable metastases of gastrointestinal stromal tumours”. European Journal of Gastroenterology and Hepatology 16 (2004): 1237-1239.
    21. Takaki H., et al. “Embolización de la arteria hepática para la metástasis hepática de un tumor del estroma gastrointestinal después de la terapia con imatinib y sunitinib”. Revista de Cáncer Gastrointestinal 4 (2014): 494-499.
    22. Joensuu H. “Risk stratification of patients diagnosed with gastrointestinal stromal tumor”. Human Pathology 39 (2008): 1411-1419.
    23. Hohenberger P., et al. “Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour”. British Journal of Surgery 97 (2010): 1854-1859.
    24. DeMatteo RP., et al. “Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial”. Annals of Surgery 3 (2013): 422-429.
    25. Von Mehren M and Joensuu H. “Gastrointestinal Stromal Tumors”. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2 (2018): 136-143.
    26. Waidhauser J., et al. “Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia”. World Journal of Gastroenterology 30 (2019): 4261-4277.
    27. Akahoshi K., et al. “Current clinical management of gastrointestinal stromal tumor”. World Journal of Gastroenterology26 (2018): 2806-2817.
    28. Ahmed M. “Recent advances in the management of gastrointestinal stromal tumor”. World Journal of Clinical Cases15 (2020): 3142-3155.
Citation: Juan Carlos Rivera Martínez., et al. “Tumors of the Gastrointestinal Stroma. Surgical Management and Tyrosinase Inhibitors (ITK)”. EC Gastroenterology and Digestive System 8.3 (2021): 63-69.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.